Loading, please wait ...


News Analytics

Biogen Hillerød, Denmark  jpg?tqLDCI2oCjz0PiVk2zxW MvNPCrI7RTK.
Earlier studies found the current thrombolytic therapy, tissue plasminogen activator, causes sICH in up to 6% of patients who receive the treatment up to nine hours after stroke onset.

Subject Matter

  • Healthcare 64.47%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 35.53%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions